enlightenbio  Blog

Industry News in Genomics, Genetics, Precision Medicine, and Beyond

Find here a listing of the latest industry news in genomics, genetics, precision medicine, and beyond. We will update and add to this page on a regular basis. This page is not a compilation of all relevant information but rather contains some key highlights that we consider to be of importance to share with the community.

Sign-Up for our newsletter and never miss out on the latest news and updates.

Check out our News Dashboard with real-time listing of news and articles in genomics, genetics, precision medicine, and beyond.

News for the month of August 2022

Funding / IPO

Precision Medicine

(Genomics) Data Platforms / Analysis / Instruments

Genomic / Genetic Testing / Liquid Biopsy

CRISPR / Cas9 Technology

Miscellaneous

Publication

News for the month of July 2022

Funding / IPO

Mergers & Acquisitions

Precision Medicine

Genomic / Genetic Testing / Liquid Biopsy

(Genomics) Data Platforms / Analysis / Instruments

Saptial Omics Platforms

Microbiome

CRISPR/Cas9 Technology

Miscellaneous

COVID-19 / SARS-CoV-2

Publications

News for the month of June 2022

The month of June was dominated by a slew of exciting new technology announcements coinciding with the Annual AGBT conference held earlier in the month in Orlando, FL. Much of the news centered around the latest technical advancements in spatial genomics with several new platforms being launched, single-cell analysis reported to now being FFPE enabled, and new sequencing systems with Ultima Genomics coming out of stealth mode with $600M in funding with a new high-throughput, low-cost sequencing platform that promises to deliver a $100 genome.

Top Technology announcements included:

Funding / IPO

Mergers & Acquisitions

Precision Medicine

Genomic / Genetic Testing / Liquid Biopsy

(Genomics) Data Platforms / Analysis / Instruments

RWE / RWD

CRISPR/Cas9 Technology

AI / ML

AGBT 2022

Spatial genomics / Single-cell genomics

Sequencing systems

Sequencing automation / reagents

CRISPR technology

Metagenomics

Miscellaneous

COVID-19/SARS-CoV-2

Publications

News for the month of May 2022

During the month of May several worthwhile initiatives have either been completed or just started. This includes 54gene completing its first consortium-led publication in Nature Genetics related to a study on over 100,000 Nigerians: “Promoting the Genomic Revolution in Africa through the Nigerian 100k Genome Project”. Similarly, over the course of the next three years, the whole genomes of 100,000 healthy Singaporeans will be sequenced and analyzed to create one of Singapore’s largest research data sets. Both these initiatives will increase the diversity in genomic studies, and will therefore be important resources that are expected to play a key role for African and Asian populations to allow them to benefit from the global efforts at advancing precision medicine for various diseases.

Other business news included InformedDNA announcing evidence-based genomics decision support service, InformedGENOMICS for health plans which will equip medical directors and clinical reviewers with ready-to-use criteria and clinical utility reviews, Thermo Fisher Scientific and Qatar Genome Program partnering to advance precision medicineBC Platforms, Euformatics and Oncompass Medicine forming a partnership to develop oncology NGS workflows for buyer consortium of seven major European hospitals, Tempus launching psychiatric Real-World Data ProgramNanoString launching an integrated informatics workflow which couples the GeoMx instrument to automated downstream data processing using the Illumina DRAGEN™ Bio-IT platform, and Illumina stepping deeper into drug discovery with Deerfield, Janssen partnerships.

Funding / IPO

Precision Medicine

RWE / RWD

(Genomic) Data Platforms / Analysis

Miscellaneous

Digital Health

Spatial Genomics

SARS-CoV-2 / COVID-19

Publications

News for the month of April 2022

In April major attention was given to the completion of the human genome sequence, published March 31. Nearly 20 years after the Human Genome Project sequenced 92% of the human genome, scientist just only now published the first truly 100% complete genome. The effort involved an unprecedented, grassroots collaboration of scientists around the world who applied novel long-read sequencing technologies (Oxford Nanopore and PacBio technologies) to sort through massive, previously unmapped strands of DNA located primarily in the dense centers of human chromosomes. The T2T-CHM13 version includes the sequence of almost 200 million base pairs that were missing in the previously used reference genome, GRCh38, published by the Genome Reference ConsortiumTrusted Source. Besides filling the gaps in the genome, the T2T-CHM13 genome has also corrected errors present in GRCh38.

On the business side highlights for the month of April included Pharmaceutical Companies launching the Precision Cancer Consortium to drive global access to comprehensive genomic testing for all patients with cancerSOPHiA GENETICS hitting a major milestone of One Million Genomic Profiles analyzed by the SOPHiA DDM™ Platformreal-world data and AI startup ConcertAI scoring $150M, valuation skyrocketing to nearly $2B, and AI startup Unlearn adding $50M for better, faster, smaller & cheaper clinical trials, just to name a few.

Funding / IPO

Mergers & Acquisitions

Precision Medicine

(Genomic) Data Platforms / Analysis

Genetic Testing / Genomic Profiling

Liquid Biopsy-based Testing

RWE / RWD

Spatial Genomics

SARS-CoV-2 / COVID-19

Digital Health

EMR / EHR

Microbiome

Miscellaneous

Publications

News for the month of March 2022

Highlights for the month of March included the All of Us Research Program, after it started nearly four years, releasing nearly 100,000 whole genome sequences which sets the stage for new discoveries, the NIH searching for a new leader after Collins’ retirement, new blood biomarker suggested to predict dementia risk in Mexican Americans, and study demonstrating early-stage multi-cancer detection using an extracellular vesicle protein-based blood test and AI-enabled marker analysis.

The business news were plentiful and included Thermo Fisher Scientific launching CE-IVD Marked NGS instrument for use in clinical labsPacBio opening European Headquarters in LondonBC Platforms opening Singapore R&D Center and signing new data partnership in Asia Pacific regionGenomenon raising $20M in Series Bthe Broad Institute selecting Fabric Genomics for implementation of clinical whole genome sequencing offeringDNAnexus securing $200M in Series H (bringing its total funding to almost $0.5B)Illumina wining extended U.S. ban on BGI gene-sequencer sales in addition to releasing DRAGEN v3.10, and lastly Hindenburg Research publishing a report on Natera’s medical billing practicessuggesting Natera’s revenue growth has been fueled by deceptive sales and billing practices aimed at doctors and insurance companies.

SARS-CoV-2 / COVID-19

Funding / IPO

Mergers & Acquisitions

Precision Medicine

Genomic / Genetic Testing

Genomic Data Platforms / Analysis

Sequencing Technology

Single-Cell / Spatial Genomics

Artificial Intelligence / Machine Learning

Metagenomics

Miscellaneous

Publications

News for the month of February 2022

SARS-CoV-2 / COVID-19

Funding / IPO

Mergers & Acquisitions

Precision Medicine

Genomics Data Platforms / Analysis

Microbiome

Genomic / Genetic Testing / Liquid Biopsy

Single-Cell / Spatial Genomics

Miscellaneous

Publications

News for the month of January 2022

January is typically taken over by the Annual JP Morgan conference, usually held in San Francisco, but this year because of COVID, the conference was yet again held remotely. This healthcare conference tends to be rich in exciting announcements which often lay the ground for what is to come as major trends throughout the year. One often says it’s a window to what is just around the corner for the coming year, and we’d expect this to hold true also for 2022.

Interestingly, the conference started out with Illumina posting new sales record numbers and making a splash with two separate announcements: (1) the announcement of a new sequencing-by-sequencing chemistry (codenamed “Chemistry X) to gear up for its long-read Infinity which is scheduled to launch later this year, and (2) the collaboration with Nashville Biosciences to establish a clinico- genomic resource in alliance with multiple pharma industry partners.

Additional JP Morgan Healthcare Conference Highlights

SARS-CoV-2 / COVID-19

Funding / IPO

Mergers & Acquisitions

Partnerships / Collaborations

Precision Medicine

Sequencing Platforms

Genomics Data Analysis

Miscellaneous

Publications

Following are archived industry news

Industry News – 2021

Industry News – 2020

Industry News – 2019

Industry News – 2018

Industry News – 2017

COVID-19 / SARS-CoV-2

Collated COVID-19/SARS-CoV-2 Information

ADVERTISEMENT

Your Header Sidebar area is currently empty. Hurry up and add some widgets.

%d bloggers like this: